The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.

"This research provides crucial insights into how the immune system functions in sickle cell disease," said Dr. Karina Yazdanbakhsh, Vice President and Director of Research at New York Blood Center ...

By Tarun Sai Lomte A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...

ADMA Biologics’ ADMA shares have lost 8.9% in a month against the industry’s growth of 6.6%. The company has put up a ...

I know there is both a growing interest in – and quite a bit of confusion about – the state of COVID-19 antibody testing. I wanted to take a moment to clear up some of the confusion.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...